SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Cantourage UK Brings Together Pharma’s Uganda-Grown Medical Cannabis To The United Kingdom

    By

    CANTOURAGE UK and Israeli medical cannabis producer Together Pharma (TASE: TGTR) have brought the first Ugandan medical cannabis to the United Kingdom. From today, patients throughout the UK will have access to two of Together Pharma’s high-THC genetics: Glueberry OG® and Power Plant.

    Cantourage UK, a subsidiary of Berlin-based European medical cannabis leader Cantourage, has successfully imported the dried flower products from Germany. Cantourage UK will offer Together Pharma’s high-THC, non-irradiated medical cannabis flowers to patients immediately through Cantourage Clinic.

    Together Pharma is the only cultivator of medical cannabis in Uganda. Its Ugandan farm extends over some approx. 30,000 sqm Greenhouses and has a full production capacity of more than 15 tonnes annually, including a range of innovative cultivars which will be introduced into the UK’s medical cannabis market over the next few months.

    As of today, Cantourage has signed contracts with over 20 leading cultivators from 13 different countries. Together Pharma is the first company to launch products grown in Africa via Cantourage’s Fast Track Access Platform.

    Niall Ivers, COO at Cantourage UK: “We’re delighted to be extending our successful partnership with Together Pharma into the UK. Together Pharma is a market leader in the Israeli domestic market with extensive knowledge and international experience in delivering high-quality, great-value medicines to patients. We’re confident the introduction of these first two varieties will assist in building a sustainable eco-system for UK patients.”

    Nir Sosinsky, Managing Director of Together Pharma, added: “Our extended partnership with Cantourage UK is extremely exciting for Together Pharma and a new stage in the expansion of our global reach. It strengthens our position in the UK and Europe, while at the same time underpinning our commitment to Uganda’s cannabis industry, which holds great future potential for the country. The United Kingdom is an extremely important market for us. We are glad that our medical-grade cannabis flowers are being made available through Cantourage UK and Cantourage Clinic, allowing for a reliable supply to the benefit of patients across the country.”

    BusinessCann

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free